Source facts
FDA posted a tentative approval letter for TIVOZANIB on 2026-07-21. This is the document posting date; consult the signed letter for the decision date. The source metadata identifies ANDA 220437 as an original application. Review the exact FDA letter for the approved conditions and labeling.
